Home/Investors/CICC

CICC

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

phase-2

Investment Focus

Gastrointestinal Diseases Central Nervous System Diseases Cardiovascular Diseases Oncology Infectious Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Triastek	phase-2	—	Gastrointestinal Diseases, Central Nervous System Diseases
Immunofoco	phase-3	—	Oncology, Infectious Diseases

Frequent Co-Investors

Sequoia Capital China1 shared Public Markets1 shared TF Capital1 shared GL Ventures1 shared China Life Private Equity1 shared